Assyro AI
FDA 483 Database

FDA Form 483s Issued in September 2025

Every published Form FDA 483 issued in September 2025, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

19

Published 483s in September 2025

19

Distinct firms

Form 483s issued in September 2025

Intas Pharmaceutical LimitedFDA
FEI
3005890633
Issued
Sep 17, 2025
Establishment
Drug Product Manufacturer
Location
India
Zydus Lifesciences LimitedFDA
FEI
3013712903
Issued
Sep 5, 2025
Establishment
Sterile Drug Manufacturer
Location
India
Baxter Oncology GmbHFDA
FEI
3002806419
Issued
Sep 26, 2025
Establishment
Drug Manufacturer
Location
Germany
Petscript IncFDA
FEI
3010282564
Issued
Sep 18, 2025
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Texas, United States
Lupin LimitedFDA
FEI
3015392060
Issued
Sep 16, 2025
Establishment
Sterile Drug Manufacturer
Location
India
Qualgen LLCFDA
FEI
3011286349
Issued
Sep 4, 2025
Establishment
Outsourcing Facility
Location
Oklahoma, United States
Biocon Biologics LimitedFDA
FEI
3015283245
Issued
Sep 3, 2025
Establishment
Drug Manufacturer
Location
India
Sun Pharmaceuticals Medicare Ltd.FDA
FEI
3002957541
Issued
Sep 19, 2025
Establishment
Finished Pharmaceutical Manufacturer
Location
India
ProRx LLCFDA
FEI
3022250654
Issued
Sep 19, 2025
Establishment
Outsourcing Facility
Location
Pennsylvania, United States
Park Avenue CompoundingFDA
FEI
1972829
Issued
Sep 23, 2025
Establishment
Outsourcing Facility
Location
Missouri, United States
Central Admixture Pharmacy Services IncFDA
FEI
3009590582
Issued
Sep 5, 2025
Establishment
Outsourcing Facility
Location
Pennsylvania, United States
Farmakeio Outsourcing LLCFDA
FEI
3014982757
Issued
Sep 5, 2025
Establishment
Outsourcing Facility
Location
Texas, United States
Central Admixture Pharmacy Services IncFDA
FEI
3014307835
Issued
Sep 5, 2025
Establishment
Outsourcing Facility
Location
Arizona, United States
North American Custom Laboratories LLCFDA
FEI
3014229024
Issued
Sep 5, 2025
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Texas, United States
Fareva AmboiseFDA
FEI
3000234005
Issued
Sep 16, 2025
Establishment
Sterile Drug Manufacturer
Location
France
Immacule Lifesciences Private LimitedFDA
FEI
3014210753
Issued
Sep 18, 2025
Establishment
Sterile Drug Manufacturer
Location
India
Dr. Reddy's LaboratoriesFDA
FEI
3002807544
Issued
Sep 5, 2025
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
United Kingdom
Aurobindo Pharma Ltd. Unit-XIIFDA
FEI
3004446312
Issued
Sep 5, 2025
Establishment
Drug Manufacturer
Location
India
Dr. Reddy’s Laboratories, LTD, BiologicsFDA
FEI
3014250111
Issued
Sep 12, 2025
Establishment
Drug Substance Intermediate Manufacturer
Location
India

Other months in 2025

Back to the FDA 483 Database